Dermapharm Holding SE (LON:0A5J)

Market Cap	1.73B -2.9%
Revenue (ttm)	1.02B +0.0%
Net Income	101.28M +28.1%
EPS	1.88 +28.3%
Shares Out	n/a
PE Ratio	17.09
Forward PE	15.34
Dividend	0.77 (2.13%)
Ex-Dividend Date	Jun 27, 2025

Volume	46
Average Volume	5,759
Open	37.33
Previous Close	37.33
Day's Range	37.10 - 37.40
52-Week Range	31.85 - 42.20
Beta	1.07
RSI	57.50
Earnings Date	Mar 17, 2026

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as product...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 3,551
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A5J

Financial Performance

In 2024, Dermapharm Holding SE's revenue was 1.20 billion, an increase of 3.89% compared to the previous year's 1.15 billion. Earnings were 113.79 million, an increase of 82.44%.

Financial numbers in EUR